S. Edward Torres - Net Worth and Insider Trading
S. Edward Torres Net Worth
The estimated net worth of S. Edward Torres is at least $48 dollars as of 2024-11-13. S. Edward Torres is the Director of GlobeImmune Inc and owns about 241,706 shares of GlobeImmune Inc (GBIM) stock worth over $48. Details can be seen in S. Edward Torres's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that S. Edward Torres has not made any transactions after 2016-03-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of S. Edward Torres
S. Edward Torres Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, S. Edward Torres owns 5 companies in total, including Surface Oncology Inc (SURF) , Aileron Therapeutics Inc (ALRN) , and Protagonist Therapeutics Inc (PTGX) among others .
Click here to see the complete history of S. Edward Torres’s form 4 insider trades.
Insider Ownership Summary of S. Edward Torres
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SURF | Surface Oncology Inc | 2018-04-18 | 10 percent owner |
| ALRN | Aileron Therapeutics Inc | 2017-06-28 | 10 percent owner |
| PTGX | Protagonist Therapeutics Inc | 2016-08-10 | 10 percent owner |
 | | 2016-04-06 | 10 percent owner |
| | 2016-03-17 | director |
S. Edward Torres Latest Holdings Summary
S. Edward Torres currently owns a total of 1 stock. S. Edward Torres owns 241,706 shares of GlobeImmune Inc (GBIM) as of March 17, 2016, with a value of $48.
Latest Holdings of S. Edward Torres
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GBIM | GlobeImmune Inc | 2016-03-17 | 241,706 | 0.00 | 48 |
Holding Weightings of S. Edward Torres
S. Edward Torres Form 4 Trading Tracker
According to the SEC Form 4 filings, S. Edward Torres has made a total of 0 transactions in GlobeImmune Inc (GBIM) over the past 5 years. The most-recent trade in GlobeImmune Inc is the sale of 26,188 shares on March 17, 2016, which brought S. Edward Torres around $43,734.
Insider Trading History of S. Edward Torres
- 1
S. Edward Torres Trading Performance
S. Edward Torres Ownership Network
Ownership Network List of S. Edward Torres
Ownership Network Relation of S. Edward Torres
S. Edward Torres Owned Company Details
What does Surface Oncology Inc do?
Who are the key executives at Surface Oncology Inc?
S. Edward Torres is the 10 percent owner of Surface Oncology Inc. Other key executives at Surface Oncology Inc include Deputy GC Chandra Adams , Chief Medical Officer Alison Oneill , and See Remarks Jessica Fees .
Surface Oncology Inc (SURF) Insider Trades Summary
Over the past 18 months, S. Edward Torres made no insider transaction in Surface Oncology Inc (SURF). Other recent insider transactions involving Surface Oncology Inc (SURF) include a net sale of 16,713 shares made by Robert W. Ross , a net sale of 9,434 shares made by Jessica Fees , and a net sale of 7,042 shares made by Alison Oneill .
In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,090 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,090 shares.
Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Surface Oncology Inc Insider Transactions
S. Edward Torres Mailing Address
Above is the net worth, insider trading, and ownership report for S. Edward Torres. You might contact S. Edward Torres via mailing address: C/o Lilly Ventures Fund I Llc, 115 W. Washington St, Ste 1680 South, Indianapolis In 46204.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
